NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study

Phase

SUSPENDED

Status

Enrollment

NIH

Sponsor class

Stopped Enrollment has been put on hold by the sponsor to allow for further engineering evaluation and performance review of the investigational device, as well as reassessment of the underlying device reliability assumptions.

Conditions

Tricuspid Valve Insufficiency

Interventions

DEVICE: TRAIPTA (Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)